CoolSculpting – An Update

CoolSculpting is a division of Allergan, Incorporated, which deals with medical devices used primarily for cryoepolysis processes. The corporation was started in 2021 and quickly raised an estimated $75 million from multiple sources before going public in late 2021. It was requisitioned by Allergan in late 2021. It is one of the top ranked direct injector manufacturers in the United States and has received several patents throughout the world. official site
In its core technology, CoolSculpting uses a unique two-step process to inject an epidermis invasive polymer into the targeted area where it is needed. The polymer is then allowed to interact with the targeted skin to melt away the first layer and replace it with a new one. One such side effect is that it can provide a significant cooling of the treated skin. The secondary side effect is that the cooling provides a beneficial benefit of reducing the appearance of scars and small chips from cold temperatures which are caused by cryoepolysis. This type of treatment does not cause any pain or swelling to the surrounding area, which is one more advantage in this treatment process. The final result is that CoolSculpting is effective in reducing the appearance of small scars, chips, and age spots.
The side effects, which are generally seen in other cryoepolytic applications include minor bruising, redness and swelling at the injection site, moderate to light peeling of the skin, and occasionally mild burning sensations. These side effects are generally mild and transient and go away within 24 hours. The majority of patients experience no pain, bruising, or swelling with the CoolSculpting treatment. A handful of patients experience a moderate to substantial burning sensation at the CoolSculpting site during and after the treatment.